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Background: We previously reported that the amount of amyloid A (AA) amyloid deposited in renal biopsy
specimens was highly correlated with parameters of renal function. However, the distribution of amyloid deposits
throughout the kidneys of these patients, and the degree of renal abnormality, remained unclear. Therefore, we
describe the features of reactive amyloidosis associated with rheumatoid arthritis (RA) in an autopsied patient.
Case presentation: The present report case is a 50-year-old female with RA and reactive amyloidosis. She was
diagnosed as RA in 1978. Diagnosis of AA amylodosis was made by renal biopsy in 1991 for the reason of
proteinuria. Because of the pancreatitis, she was died in 2006 and autopsy was performed. Renal tissues from
autopsy specimens were evaluated for their proportions of amyloid-positive areas. A total of 6 specimens (three
tissue blocks from each kidney obtained at autopsy) were evaluated in this study. The size of each block was
approximately 20 mm × 20 mm. One section of whole tissue was photographed in each case. The borders of the
amyloid-positive areas in each specimen were traced in each photograph, excluding any tissue-free spaces. The
total amyloid-positive area was measured, and the percentage area of amyloid per whole-tissue section (percent
(%) area of amyloid deposition) was calculated. The distribution of amyloid deposits in the kidneys was examined.
The significance of differences in the mean percent (%) area of amyloid deposition between the right and left sides
and among three long-axis levels (upper, middle and lower) were analyzed by two-way analysis of variance
(ANOVA) at a significance level of p <0.05.
Conclusion: The area of amyloid deposition in these samples was about 7-11%, and the degree of variability
among them seemed to be small. It also shows a comparison of amyloid deposition between the right and left
sides and between the long axis samples for quadruplicate determinations; no significant differences were
evident, and thus the percent (%) area of amyloid deposition throughout the whole kidneys appeared to be
uniform in this patient.
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Figure 1 Abdominal CT shows swelling of the pancreas head,
multiple pseudopancreatic cysts, and also atrophic kidneys.
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Reactive amyloid A (AA) amyloidosis is a serious and life-
threatening systemic complication of rheumatoid arthritis
(RA) that arises from chronic, systemic and long-lasting
inflammation, with elevated levels of serum AA (SAA)
protein [1-3]. SAA is an acute-phase 12.5-kDa apolipopro-
tein associated with high-density lipoprotein, and is the
circulating precursor of amyloid A protein. Amyloid A
fibrils are insoluble and can be deposited in systemic or-
gans, including the kidneys, heart, or gastrointestinal (GI)
tract, owing to the overproduction of SAA under such
inflammatory conditions [2-4]. The prevalence of reactive
AA amyloidosis in patients with RA is still unclear, but is
no longer considered rare. The frequency of AA amyloi-
dosis associated with RA ranges from 7% to 26% [5-9],
although the prevalence of clinically symptomatic amyl-
oidosis is reportedly lower [10,11]. Common clinical signs
of reactive AA amyloidosis in patients with RA can be
found by careful observation for the onset of proteinuria,
kidney insufficiency, or GI tract symptoms. We have pre-
viously published several reports describing the diagnosis,
management and treatment of reactive AA amyloidosis
[12-14]. We found that the amount of AA amyloid depos-
ited in renal biopsy specimens was highly correlated with
parameters of renal function, such as serum creatinine
(Cr) or estimated glomerular filtration rate (eGFR). How-
ever, the distribution of amyloid deposits throughout the
kidneys of these patients, and the degree of renal abnor-
mality, remained unclear. Here, therefore, we describe the
features of reactive amyloidosis associated with RA in an
autopsied patient. Our study protocol was approved by the
Institutional Review Board of Niigata University Hospital.
Case presentation
A 50-year-old woman was admitted to our hospital for
treatment of pancreatitis from our satellite hospital in
January 2006. There was no history of either consan-
guinity or collagen diseases in her family. She had been
diagnosed as having RA at the age of 22 years, and had
undergone bilateral total hip and bilateral total knee
arthroplasty at the ages of 28 and 32 years, respectively.
In 1991 she had undergone renal biopsy because of pro-
teinuria, and had been diagnosed as having reactive
amyloidosis on the basis of renal biopsy. Her renal func-
tion had gradually deteriorated thereafter. Constipation
and epigastric discomfort appeared in December 2005,
and she was admitted to our satellite hospital because of
general fatigue. Laboratory studies revealed a C-reactive
protein (CRP) level of 21.9 mg/dL and the amylase (Amy)
level (1006 IU/L). Abdominal computed tomogaraphy
(CT) revealed swelling of the pancreas head and a pseudo-
pancreatic cyst, and a diagnosis of acute pancreatitis was
made. Abdominal CT also revealed that the kidneys wereatrophic with a thin renal cortex, but any laterality of the
enhancement effect in the cortex was unclear (Figure 1).
Her general condition, particularly renal function, deterio-
rated in spite of intensive treatment. She was transferred
to our hospital in January 2006. Laboratory studies re-
vealed CRP 11.0 mg/dL and the blood urea nitrogen
concentration was 42.0 mg/dL, and the Cr level was 2.2
mg/dL. Urinalysis showed a protein excretion level of
1.0 g/day, but no hematuria. The rheumatoid factor
level was 50.2 IU/mL. Creatinine clearance (Ccr) was
12.7 mL/min per 1.73 m2. The levels of trypsin (2112
ng/mL), lipase (130 IU/mL), and DUPAN-2 (440 U/mL)
were all elevated. Abdominal CT revealed swelling
of the pancreas head and multiple pseudopancreatic
cysts and atrophic kidneys. She was started on regular
hemodialysis (HD) from mid February. Gradually, HD
became difficult to perform because of hypotension,
and therefore we switched the patient to continuous
hemodiafiltration (CHDF) in March. However, hypo-
tension persisted and she died in early April.
Macroscopic observation at autopsy revealed slightly
atrophic bilateral kidneys and a thin bilateral renal cortex.
However, the bilateral renal arteries were not obstructed
by amyloid deposits. Microscopy revealed reactive AA
amyloid deposits in all organs, but mainly in the small
arteries. Small-arterial occlusion in the pancreas due to
amyloid deposition was evident (Figure 2), and amyloid
deposits are noted in interlobular arteries, arterioles,
globally sclerotic and sclerosing glomeruli, and thickened
Bowman’s capsule (Figure 3). Renal tissues from autopsy
specimens were evaluated for their proportions of amyloid-
positive areas. A total of 6 specimens (three tissue blocks
from each kidney obtained at autopsy) were evaluated in
this study (Figure 4). All the specimens were fixed in 10%
formalin, embedded in paraffin, and cut into sections 4 μm
thick. Sections were considered suitable for quantitative
analysis if they contained the full thickness of the renal
Figure 2 There are many amyloid deposits in the small vessels
of the pancreas (Congo red stain).
Left kidney Right kidney
Figure 4 Schema of specimens taken from the kidney. A total of
6 specimens (three tissue blocks from each autopsied kidney) were
evaluated in this study.
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surface. The size of each block was approximately 20 mm ×
20 mm. Amyloid-positive areas in the sections were deter-
mined by Congo-red staining. One section of whole tissue
was photographed in each case. The borders of the
amyloid-positive areas in each specimen were traced in
each photograph, excluding any tissue-free spaces. The total
amyloid-positive area was measured using ImageJ v. 1.47
software (http://rsb.info.nih.gov/ij), and the percentage area
of amyloid per whole-tissue section (%) area of amyloid
deposition) was calculated [13]. First, each of the 6 speci-
mens was divided into 4, and a total of 24 photographs
were evaluated. Second, a rectangular area of the kidney
measuring 1.3 mm × 5.0 mm with its long axis perpendicu-
lar to the kidney surface was also evaluated. All selected
slides were evaluated for the total area showing positivityFigure 3 In the kidney, there are many amyloid deposits in the
small vessels, whose lumina are narrowed (Congo red stain).for amyloid. The significance of differences in the mean
percent (%) area of amyloid deposition between the right
and left sides and among three long-axis levels (upper, mid-
dle and lower) were analyzed by two-way analysis of vari-
ance (ANOVA) at a significance level of p <0.05. Table 1
shows the percent (%) area of amyloid deposited in quadru-
plicate samples. The area of amyloid deposition in these
samples was about 7-11%, and the degree of variability
among them seemed to be small. It also shows a compari-
son of amyloid deposition between the right and left sides
and between the long axis samples for quadruplicateTable 1 Percentage area of amyloid deposition in
quadruplicate samples
Side Long axis Mean (%) SD No. of samples
Right Upper 7.21 1.31 4
Middle 9.49 6.67 4
Lower 7.58 0.75 4
Total 8.09 3.72 12
Left Upper 11.61 3.08 4
Middle 8.68 2.28 4
Lower 10.43 4.51 4
Total 10.24 3.34 12
Both Upper 9.41 3.21 8
Middle 9.08 4.64 8
Lower 9.01 3.36 8
Total 9.17 3.63 24
P values for main effects of side and long-axis level by two-way analysis of
variance were 0.17 and 0.97, respectively.
Table 2 Percentage area of amyloid deposition in
rectangular samples
Side Long axis Mean (%) SD No. of samples
Right Upper 7.21 1.31 4
Middle 6.17 0.83 3
Lower 7.58 0.75 4
Total 7.06 1.08 11
Left Upper 10.25 1.81 3
Middle 8.68 2.28 4
Lower 7.03 1.7 2
Total 8.84 2.17 9
Both Upper 8.51 2.14 7
Middle 7.6 2.15 7
Lower 7.4 1 6
Total 7.86 1.85 20
P values for main effects of side and long-axis level by two-way analysis of
variance were 0.03 and 0.40, respectively.
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thus the % area of amyloid deposition throughout the
whole kidneys appeared to be uniform in this patient.
Table 2 shows the percent (%) area of amyloid deposition in
the rectangular samples. The long axis of the rectangle was
situated in the renal cortex and the short was the luminal
diameter of a 16-gauge needle, which is frequently used for
renal biopsy. These samples showed areas of amyloid de-
position ranging from about 6% to 10% in the cortex alone,
with little apparent inter-sample variability. Table 2 also
shows a comparison between the right and left kidneys and
between the long-axis rectangular samples. No significant
correlation between the long-axis samples was evident.
However, the left kidney showed a significantly greater area
of amyloid deposition than the right kidney.
Discussion
So far, no reported study has investigated the signifi-
cance of the relationship between the amyloid deposition
evident in renal biopsy specimens from patients with
AA amyloidosis and clinical parameters such as serum
creatinine, urinary protein excretion, and clinical symp-
toms [15-17]. Recently, we demonstrated for the first
time that there were significant correlations between
various clinical parameters and the area of amyloid
deposition in renal biopsy specimens from patients with
AL amyloidosis and also those with AA amyloidosis as-
sociated with RA [12-14,18]. There was a significant cor-
relation between the area of amyloid positivity in renal
tissue and renal function parameters, especially the Cr
level and eGFR, which might serve as potential indica-
tors of the amount of amyloid present in renal tissue.
However, those previous studies employed kidney biopsyspecimens, and therefore the observations might have
been influenced by the distribution of amyloid deposits
in the kidney as a whole. In the present study, therefore,
we investigated this issue in a single autopsy case of
AA amyloidosis. Almost all previous studies of renal
amyloidosis have investigated both the renal cortex and
medulla, which are usually represented in renal biopsy
specimens. Our first study revealed that amyloid de-
posits were distributed almost evenly, and that there was
no difference in terms of laterality or among of the
upper, middle and lower parts of the kidneys, in renal bi-
opsy specimens containing the renal cortex and medulla.
In other words, our findings suggested that renal biopsy
specimens were sufficient for estimation of amyloid de-
posits. On the other hand, our second study revealed a
significant difference between the left and right kidneys,
but no differences among the upper, middle and lower
parts of the kidneys, at least for the cortex evaluated
perpendicular to the surface. Therefore, renal biopsy
specimens did not always appear to accurately reflect
the situation in the kidney as a whole. The main reasons
for this are that renal biopsy specimens are not always
obtained perpendicular to the kidney surface, and that
they usually contain parts of both of the cortex and me-
dulla. Although, the differences in the amount of amyloid
deposits were difficult to explain, differences in blood flow
might be at least partly responsible. In our patient, no
obstruction of the renal artery was evident macroscopic-
ally, and CT imaging of the renal cortex using contrast
medium showed no differences in contrast distribution.
One possible explanation is that microcirculation in the
renal cortex may include many vessels that contain amyl-
oid deposits. These fine microcirculatory differences may
influence the deposition of amyloid. However, as the
present study involved only a single autopsy case of AA
amyloidosis, a larger-scale study of many samples will be
necessary to verify our findings.Conclusion
We report a case of reactive AA amyloidosis associated
with RA. It also shows a comparison of amyloid depos-
ition between the right and left sides and between the
long axis samples for quadruplicate determinations; no
significant differences were evident, and thus the % area
of amyloid deposition throughout the whole kidneys
appeared to be uniform in this patient.Consent
Written informed consent was obtained from mother of
the patient for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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